☰

Amit Dutt, Ph.D.

Affiliations: 
Department of Genetics University of Delhi South Campus 
Area:
Cancer genomics, Cancer genetics, Human genetics, Cancer
Website:
https://www.actrec.gov.in/pi-webpages/AmitDutt/dutt_index.html
Google:
"Amit Dutt"
Bio:

Dr. Amit Dutt, a Professor at the Department of Genetics, University of Delhi South Campus, and a Principal Investigator at the Advanced Centre for Treatment, Research, and Education in Cancer (ACTREC), Tata Memorial Centre, Mumbai, spearheads a pioneering research team revolutionizing cancer treatment through the lens of genomic intricacies. With a postdoctoral tenure at the Broad Institute of MIT and Harvard, and a Ph.D. in Developmental Biology from the University of Zurich, Dr. Dutt's expertise is sought-after in the realms of lung, breast, and head and neck cancers. His multifaceted interests extend to devising innovative computational methodologies for analyzing expansive cancer genome datasets and investigating the microbial agents implicated in human carcinogenesis. Well known for his publications in esteemed scientific journals, Dr. Dutt has garnered numerous accolades and distinctions for his impactful contributions to the field of cancer research, including most coveted Shanti Swarup Bhatnagar Award in Medical Sciences.
(Show less)

Mean distance: (not calculated yet)
 
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
Alex Hajnal grad student 2000-2004 University of Zurich (UZH)
Adriano Aguzzi post-doc 2004-2005 University Hospital, Zurich
Matthew Meyerson post-doc 2005-2010 Dana Farber Cancer Institute

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Noronha V, Budukh A, Chaturvedi P, et al. (2024) Uniqueness of lung cancer in Southeast Asia. The Lancet Regional Health. Southeast Asia. 27: 100430
Desai S, Ahmad S, Bawaskar B, et al. (2024) Singleton mutations in large-scale cancer genome studies: uncovering the tail of cancer genome. Nar Cancer. 6: zcae010
Chougule A, Chandrani P, Noronha V, et al. (2023) Real-World Evidence of EGFR Targeted Therapy in NSCLC- A Brief Report of Decade Long Single Center Experience. Jto Clinical and Research Reports. 4: 100566
Joshi A, Butle A, Hait S, et al. (2022) Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation. Translational Oncology. 22: 101461
Butle A, Joshi A, Noronha V, et al. (2021) Weekly osimertinib dosing prevents EGFR mutant tumor cells destined to home mouse lungs. Translational Oncology. 14: 101111
Togar T, Desai S, Mishra R, et al. (2020) Identifying cancer driver genes from functional genomics screens. Swiss Medical Weekly. 150: w20195
Gupta S, Chaubal R, Gardi N, et al. (2020) Abstract P3-05-01: Molecular effects of surgical resection on primary breast tumor Cancer Research. 80
Sikder S, Kumari S, Kumar M, et al. (2019) Chromatin protein PC4 is downregulated in breast cancer to promote disease progression: Implications of miR-29a. Oncotarget. 10: 6855-6869
Arora R, Rekhi B, Chandrani P, et al. (2019) Merkel cell polyomavirus is implicated in a subset of Merkel cell carcinomas, in the Indian subcontinent. Microbial Pathogenesis. 103778
Noronha V, Patil VM, Joshi A, et al. (2019) Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in -Mutated Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901154
See more...